| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.01 | 0.7 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.014 | 0.8 |